Paysign, Inc. (PAYS)

Over the past six months, Paysign's stock has experienced significant growth. Key events impacting the stock include the Q4 2025 earnings report, which showed a revenue increase but missed EPS estimates, and the upcoming Q1 2026 earnings call. An insider sold shares of common stock under a pre-arranged trading plan. Paysign has received a consensus rating of "Moderate Buy" from analysts, with a potential upside from its current price.

Paysign experiences demand seasonality in its core business segments. Demand in the plasma segment is typically lowest in the first quarter, while demand in the pharmaceutical segment is generally highest in the first quarter. The company's overall revenue growth is driven by the expanding plasma donation market and the growing pharmaceutical co-pay assistance market.

Paysign, Inc. is a financial technology company specializing in prepaid card programs and integrated payment processing services, operating within the Technology sector and the Software - Infrastructure industry. The company provides prepaid card programs, patient affordability offerings, donor compensation solutions, digital banking services, life science software technology solutions, and integrated payment processing services. Paysign's services are utilized across diverse industries such as pharmaceuticals, healthcare, hospitality, retail, and government sectors.

Paysign, Inc. is headquartered in Henderson, Nevada, United States, primarily serving businesses, consumers, and government institutions within the United States. Approximately 95% of Paysign's revenue is generated outside of Nevada, indicating a broad operational presence across the U.S. The company recently expanded its operational capacity by opening a new patient service support center in Henderson, Nevada.

Paysign's brand reputation appears positive, driven by strong financial performance and strategic growth. The company has experienced rapid scaling of its patient affordability business and consistent revenue growth and profitability. Expansion and industry engagement further solidify its position. A Q3 2025 EPS miss raised some concerns, but it appears to be a minor setback.

Paysign's ownership structure includes institutional, retail, and individual investors. Institutional investors hold a significant percentage of the company's stock, with major shareholders including Topline Capital Management, LLC, BlackRock, Inc., and Vanguard Group Inc. Insiders own a notable portion of the company's stock, with Mark Newcomer owning the most shares among individual investors. Public companies and individual investors collectively own a substantial portion of the stock.